Avtor/Urednik		Gaberšček, Simona
Naslov		Hipertiroza in atrijska fibrilacija
Prevedeni naslov		Hyperthyroidism and atrial fibrillation
Tip		članek
Vir		Med Razgl
Vol. in št.		Letnik 42, št. Suppl 4
Leto izdaje		2003
Obseg		str. 39-41
Jezik		slo
Abstrakt		Occurring in 10 to 15% of patients, atrial fibrillation is the second most frequent rhythm disturbance in patients with hyperthyroidism. Its incidence increases with age. Treatment goals are to lower its frequency, establish a euthyroid state and prevent complications. In 60% of middle-aged patients, spontaneous rhythm conversion occurs between weeks 8 and 12 after the euthyroid state has been established. If atrial fibrillation persists, conversion should be performed later, i. e. 4 months after establishing euthyroidism. Subclinical hyperthyroidism is an independent risk factor for the occurrence of atrial fibrillation. For a long period of time, Slovenia has been an area of iodine deficiency and an increased incidence of goiter and autonomous tissue has been observed. Before the introduction of amiodarone, an outpatient examination for thyroid diseases is recommended.
Izvleček		Atrijska fibrilacija je druga najpogostejša motnja ritma pri bolnikih s hipertirozo. Pojavi se pri 10-15% bolnikov. Pojavnost narašča s starostjo. Cilji zdravljenja so: znižati frekvenco, vzpostaviti evtirotično stanje ter preprečiti zaplete. Pri 60% bolnikov srednjih let pride do spontanega preskoka v sinusni ritem 8 do 12 tednov po vzpostavitvi evtiroze. Če atrijska fibrilacija vztraja, se za konverzijo ritma odločimo kasneje - štiri mesece po vzpostavitvi evtirotičnega stanja. Latentna hipertiroza je neodvisen dejavnik tveganja za pojav atrijske fibrilacije. V Sloveniji je zaradi dolgoletnega blagega pomanjkanja joda povečana pojavnost golše in avtonomnega tkiva. Pred načrtovano uvedbo amiodarona svetujemo pregled v tirološki ambulanti.
Deskriptorji		HYPERTHYROIDISM ATRIAL FIBRILLATION AMIODARONE